Cost-effectiveness of influenza vaccination in high-risk children in Argentina

被引:30
|
作者
Dayan, GH
Nguyen, VH
Debbag, R
Gómez, R
Wood, SC
机构
[1] Fdn Ctr Estudios Infectol, Buenos Aires, DF, Argentina
[2] Aventis Pasteur, Buenos Aires, DF, Argentina
[3] Biogen Europe, Paris, France
关键词
influenza; vaccination; cost-effectiveness;
D O I
10.1016/S0264-410X(01)00160-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: our study aimed to evaluate the cost-effectiveness of influenza vaccination in high-risk children in Argentina. Methods: a decision analysis model was performed, using data from published and unpublished sources. to compare two strategies - to vaccinate or not to vaccinate. We simulated the expected consequences of vaccination on direct medical costs, related to disease management and indirect costs, related to lost parental working days (absenteeism). Results: Using base-case assumptions vaccination of high-risk children aged 6 months to 15 years old, in Argentina (estimated cohort of 1184748) would prevent 207331 cases of influenza, resulting in a reduction of 58052 days of hospitalization and 207331 outpatient visits. Vaccination would lead to net savings of US$ 11894870 per vaccinated cohort (US$ 10.04 per vaccinated child). Conclusion: our economic analysis shows that in Argentina, routine vaccination of high-risk children against influenza would be cost saving for society. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:4204 / 4213
页数:10
相关论文
共 50 条
  • [41] Cost-effectiveness of influenza vaccination in prior pneumonia patients in Israel
    Dan Yamin
    Balicer, Ran D.
    Galvani, Alison P.
    VACCINE, 2014, 32 (33) : 4198 - 4205
  • [42] Cost-effectiveness of live-attenuated influenza vaccination among school-age children
    Wenzel, Natasha S.
    Atkins, Katherine E.
    van Leeuwen, Edwin
    Halloran, M. Elizabeth
    Baguelin, Marc
    VACCINE, 2021, 39 (02) : 447 - 456
  • [43] Cost-effectiveness analysis of dinutuximab ß for the treatment of high-risk neuroblastoma in China
    Shen, An-Le
    Zhao, Jie
    Yu, Li-Ting
    Zhang, An-An
    Wu, Bin
    Fang, Ye
    Han, Ya-Li
    Li, Chen-Sui-Zi
    Li, Zhi-Ling
    Gao, Yi-Jin
    Zhang, Shun-Guo
    PEDIATRIC BLOOD & CANCER, 2023, 70 (12)
  • [44] Cost-Effectiveness Analysis of High-Risk Groups Tuberculosis Screening in Malaysia
    Hassan, Nor Zam Azihan Mohd
    Razali, Asmah
    Shahari, Mohd Ridzwan
    Kunusagaran, Mohd Shaiful Jefri Mohd Nor Sham
    Halili, Juanita
    Zaimi, Nur Amalina
    Bahari, Mohd Shahri
    Aminuddin, Farhana
    FRONTIERS IN PUBLIC HEALTH, 2021, 9
  • [45] Cost-effectiveness of prostate cancer chemoprevention among high-risk men
    Zeliadt, Steven B.
    Ramsey, Scott D.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2010, 10 (05) : 505 - 508
  • [46] Cost-effectiveness of denosumab for high-risk postmenopausal women with osteoporosis in Thailand
    Pongchaiyakul, Chatlert
    Nanagara, Ratanavadee
    Songpatanasilp, Thawee
    Unnanuntana, Aasis
    JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (07) : 776 - 785
  • [47] The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia
    Newall, Anthony T.
    Scuffham, Paul A.
    Kelly, Heath
    Harsley, Stuart
    MacIntyre, C. Raina
    VACCINE, 2008, 26 (17) : 2142 - 2153
  • [48] Cost-Effectiveness Analysis of Switching from Trivalent to Quadrivalent Seasonal Influenza Vaccine in Argentina
    Uruena, Analia
    Micone, Paula
    Magneres, Cecilia
    Mould-Quevedo, Joaquin
    Giglio, Norberto
    VACCINES, 2021, 9 (04)
  • [49] Cost-effectiveness of rotavirus vaccination in Turkey
    Koksal, Tulin
    Akelma, Ahmet Zulfikar
    Koksal, Ali Osman
    Kutukoglu, Irem
    Ozdemir, Osman
    Yuksel, Cigdem Nuket
    Bozkaya, Davut
    Catal, Ferhat
    Sari, Sinan
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2017, 50 (05) : 693 - 699
  • [50] Cost-effectiveness of rotavirus vaccination in Mozambique
    Guimaraes, Esperanca Lourenco
    Chissaque, Assucenio
    Pecenka, Clint
    Clark, Andrew
    Vaz, Basilia
    Banze, Arlindo
    Canana, Neide
    Romao, Clesio
    Martins, Maria do Rosario Oliveira
    de Deus, Nilsa
    Debellut, Frederic
    VACCINE, 2022, 40 (36) : 5338 - 5346